Discontinued — last reported Q4 '25
Cigna Interest Paid decreased by 15.4% to $307.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.7%, from $305.00M to $307.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows relatively stable performance with a 1.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $308.00M | $311.00M | $303.00M | $308.00M | $307.00M | $308.00M | $306.00M | $322.00M | $310.00M | $387.00M | $311.00M | $336.00M | $307.00M | $394.00M | $305.00M | $379.00M | $301.00M | $363.00M | $307.00M |
| QoQ Change | — | +1.0% | -2.6% | +1.7% | -0.3% | +0.3% | -0.6% | +5.2% | -3.7% | +24.8% | -19.6% | +8.0% | -8.6% | +28.3% | -22.6% | +24.3% | -20.6% | +20.6% | -15.4% |
| YoY Change | — | — | — | — | -0.3% | -1.0% | +1.0% | +4.5% | +1.0% | +25.6% | +1.6% | +4.3% | -1.0% | +1.8% | -1.9% | +12.8% | -2.0% | -7.9% | +0.7% |